Borea Therapeutics‘ mission is to develop innovative therapeutic options for patients with genetic or chronic diseases using next-generation viral vectors. We pursue this mission through our proprietary click chemistry platform that chemically modifies adeno-associated virus (AAV) vectors, built on scientific discoveries from EMBL Institute.